BLRX

$0.00

(

+0.00%

)
Quote details

stock

BioLineRx Ltd

NASDAQ | BLRX

3.48

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$15.18M

Market Cap

-

P/E Ratio

-6

EPS

$14.80

52 Week High

$2.30

52 Week Low

HEALTHCARE

Sector

BLRX Chart

Recent Chart
Price Action

BLRX Technicals

Tags:

BLRX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $20M
Total Revenue $29M
Cost Of Revenue $9.3M
Costof Goods And Services Sold $9.3M
Operating Income -$20M
Selling General And Administrative $18M
Research And Development $9.1M
Operating Expenses $40M
Investment Income Net -
Net Interest Income -$7.3M
Interest Income $1.8M
Interest Expense $9.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4.1M
Income Before Tax -$9.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.2M
Comprehensive Income Net Of Tax -
Ebit -$147K
Ebitda $3.9M
Net Income -$9.2M

Revenue & Profitability

BLRX Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $20M
Total Revenue $29M
Cost Of Revenue $9.3M
Costof Goods And Services Sold $9.3M
Operating Income -$20M
Selling General And Administrative $18M
Research And Development $9.1M
Operating Expenses $40M
Investment Income Net -
Net Interest Income -$7.3M
Interest Income $1.8M
Interest Expense $9.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4.1M
Income Before Tax -$9.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.2M
Comprehensive Income Net Of Tax -
Ebit -$147K
Ebitda $3.9M
Net Income -$9.2M

BLRX News

BLRX Profile

BioLineRx Ltd Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BioLineRx Ltd. is a clinical-stage biopharmaceutical company based in Hevel Modi'in, Israel, focused on developing innovative therapies primarily in the oncology sector. With a robust pipeline of drug candidates targeting significant unmet medical needs in cancer treatment and other serious health conditions, BioLineRx is committed to advancing research and improving patient outcomes. The company employs cutting-edge technologies and engages in strategic partnerships to enhance its R&D capabilities, positioning itself as a critical player in the biopharmaceutical landscape, while also delivering potential value for institutional investors.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
KTTA
+61.79%
$1.71
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
INTC
+2.73%
$36.81
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-8.37%
$0.11
WULF
+6.45%
$14.84
RUBI
-8.19%
$0.21
F
+0.15%
$13.19
AMD
+3.93%
$214.24
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
TLRY
-19.39%
$0.83
SRM
+53.27%
$10.30
PFE
-0.03%
$25.71
AGNC
+1.53%
$10.56
BAC
+0.97%
$52.99
CCL
-1.12%
$25.43
BIYA
+11.34%
$0.28
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
CRWV
+4.20%
$74.29
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
ITUB
+3.23%
$7.66
NVDA
-1.02%
$178.41
AFMD
-34.94%
$0.18
HBI
-0.45%
$6.59
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
BABA
+0.37%
$157.60
SNAP
+0.23%
$7.62
NVTS
+3.86%
$8.34
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
KSS
+7.49%
$24.10
INHD
-7.00%
$0.20
NVO
+3.50%
$48.71
NAKA
+7.20%
$0.49
KDLY
+7.20%
$0.49
TMC
+7.36%
$5.83
ECDA
-3.66%
$0.53
ASST
+2.65%
$1.16
JBLU
+3.43%
$4.52
SAND
-6.04%
$12.12
CLSK
+11.96%
$15.05
LEN
+0.15%
$131.28
MBOT
+21.80%
$2.29
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
NBIS
+6.53%
$94.69
FCX
+2.62%
$42.15
AUR
+3.31%
$4.05
AMC
+1.76%
$2.30
CIFR
+6.60%
$20.41
BMNR
+6.77%
$33.89
SOLT
+7.29%
$8.97
RZLV
-0.99%
$2.98
PACB
-9.12%
$2.39
TSLG
+3.51%
$9.12
KO
+0.37%
$72.88
C
+1.31%
$102.50
BMY
+0.40%
$49.25
NEHC
+8.33%
$5.07
VICI
+0.27%
$28.83
RKLB
-1.57%
$41.93
KWM
+29.58%
$0.66
GAP
+3.49%
$27.53
CSX
+1.14%
$35.30
DEFT
+20.86%
$1.68
PFSA
+5.19%
$0.16
ZIM
+0.97%
$19.70
ONDS
-3.80%
$7.92
SANA
+14.52%
$4.02
CHR
+3.95%
$0.04
MPW
+2.12%
$5.77
CRCA
+7.60%
$3.68
WFC
+0.54%
$85.56
GOOGL
-0.33%
$318.88
MARA
+6.50%
$11.83
GPUS
+1.14%
$0.33
BBWI
+2.78%
$17.37
UPXI
-7.02%
$2.78
CRM
-2.55%
$228.15
TSLA
+0.65%
$429.38
IBRX
+2.40%
$2.13
CCCS
+0.96%
$7.32
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
KTTA
+61.79%
$1.71
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
INTC
+2.73%
$36.81
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-8.37%
$0.11
WULF
+6.45%
$14.84
RUBI
-8.19%
$0.21
F
+0.15%
$13.19
AMD
+3.93%
$214.24
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
TLRY
-19.39%
$0.83
SRM
+53.27%
$10.30
PFE
-0.03%
$25.71
AGNC
+1.53%
$10.56
BAC
+0.97%
$52.99
CCL
-1.12%
$25.43
BIYA
+11.34%
$0.28
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
CRWV
+4.20%
$74.29
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
ITUB
+3.23%
$7.66
NVDA
-1.02%
$178.41
AFMD
-34.94%
$0.18
HBI
-0.45%
$6.59
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
BABA
+0.37%
$157.60
SNAP
+0.23%
$7.62
NVTS
+3.86%
$8.34
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
KSS
+7.49%
$24.10
INHD
-7.00%
$0.20
NVO
+3.50%
$48.71
NAKA
+7.20%
$0.49
KDLY
+7.20%
$0.49
TMC
+7.36%
$5.83
ECDA
-3.66%
$0.53
ASST
+2.65%
$1.16
JBLU
+3.43%
$4.52
SAND
-6.04%
$12.12
CLSK
+11.96%
$15.05
LEN
+0.15%
$131.28
MBOT
+21.80%
$2.29
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
NBIS
+6.53%
$94.69
FCX
+2.62%
$42.15
AUR
+3.31%
$4.05
AMC
+1.76%
$2.30
CIFR
+6.60%
$20.41
BMNR
+6.77%
$33.89
SOLT
+7.29%
$8.97
RZLV
-0.99%
$2.98
PACB
-9.12%
$2.39
TSLG
+3.51%
$9.12
KO
+0.37%
$72.88
C
+1.31%
$102.50
BMY
+0.40%
$49.25
NEHC
+8.33%
$5.07
VICI
+0.27%
$28.83
RKLB
-1.57%
$41.93
KWM
+29.58%
$0.66
GAP
+3.49%
$27.53
CSX
+1.14%
$35.30
DEFT
+20.86%
$1.68
PFSA
+5.19%
$0.16
ZIM
+0.97%
$19.70
ONDS
-3.80%
$7.92
SANA
+14.52%
$4.02
CHR
+3.95%
$0.04
MPW
+2.12%
$5.77
CRCA
+7.60%
$3.68
WFC
+0.54%
$85.56
GOOGL
-0.33%
$318.88
MARA
+6.50%
$11.83
GPUS
+1.14%
$0.33
BBWI
+2.78%
$17.37
UPXI
-7.02%
$2.78
CRM
-2.55%
$228.15
TSLA
+0.65%
$429.38
IBRX
+2.40%
$2.13
CCCS
+0.96%
$7.32

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.